Emcure Pharmaceuticals Q2 Results
- BSE: 544210
- NSE: EMCURE
- ISIN: INE168P01015
- Sector: Biotechnology & Drugs
BSE
1,976.75
14.95 (0.76%)
14.95 (0.76%)Volume5.03 K
Updated: Fri 11 Sep, 2026 | 15:56:40
NSE
1,978.9016.10 (0.82%)
16.10 (0.82%)Volume1.22 L
Updated: Fri 11 Sep, 2026 | 15:50:11
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Emcure Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,935.34 | 2,180.35 | 7.54% | 1,718.01 | 12.65% |
| Depreciation/ Amortization | 104.64 | 109.51 | 5.22% | 96.90 | 8.00% |
| Operating Income | 334.48 | 400.10 | 11.15% | 283.98 | 17.78% |
| Net Income | 243.46 | 293.98 | 17.64% | 194.57 | 25.13% |
| Other Operating Expenses Total | 556.55 | 588.19 | 11.05% | 476.85 | 16.71% |
| Net Income Before Taxes | 341.42 | 393.53 | 17.42% | 273.41 | 24.87% |
| Total Revenue | 2,269.82 | 2,580.45 | 8.06% | 2,001.98 | 13.38% |
| Selling/ General/ Admin Expenses Total | 384.62 | 409.50 | -2.25% | 355.59 | 8.16% |
| Diluted Normalized EPS | 12.85 | 15.50 | 16.22% | 10.33 | 24.39% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.